IMPACT FACTOR JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOGS LaTeX 5G Tutorial Advertise
 

Search About Journals, Conferences, and Book Series


Journal of Hematology and Oncology- Impact Factor, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on June 24, 2021

Impact Factor

11.059

h-Index

 84

Rank

 354

SJR

 4.305

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Journal of Hematology and Oncology
Abbreviation J. Hematol. Oncol.
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q1); Hematology (Q1); Molecular Biology (Q1); Oncology (Q1)
h-index 84
Overall Rank/Ranking 354
SCImago Journal Rank (SJR) 4.305
Impact Score 14.57
Impact Factor 11.059 (2019)
Publisher BioMed Central Ltd.
Country United Kingdom
ISSN 17568722


About Journal of Hematology and Oncology


Journal of Hematology and Oncology is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Hematology (Q1); Molecular Biology (Q1); Oncology (Q1). It is published by BioMed Central Ltd.. The overall rank of Journal of Hematology and Oncology is 354. According to SCImago Journal Rank (SJR), this journal is ranked 4.305. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 84. The best quartile for this journal is Q1.

The ISSN of Journal of Hematology and Oncology journal is 17568722. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Hematology and Oncology is cited by a total of 5870 articles during the last 3 years (Preceding 2020).


Journal of Hematology and Oncology Impact Factor 2019-2020


The impact factor (IF) 2019 of Journal of Hematology and Oncology is 11.059, which is computed in 2020 as per it's definition. Journal of Hematology and Oncology IF is increased by a factor of 2.33 and approximate percentage change is 26.66% when compared to preceding year 2018, which shows a rising trend. The impact factor (If), also denoted as Journal impact factor (JIF), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Web of Science data.

Table Setting

Impact Factor Trend


Year wise Impact Factor (IF) of Journal of Hematology and Oncology. Based on Web of Science data.


Year Impact Factor (IF)
2020/2021Coming Soon
2019 11.059
2018 8.731
2017 7.333
2016 6.350
2015 6.263
2014 4.812
2013 4.933
2012 4.458
2011 3.990
2010 2.934

Journal of Hematology and Oncology Impact Score 2020-2021


The impact score (IS) 2020 of Journal of Hematology and Oncology is 14.57, which is computed in 2021 as per its definition. Journal of Hematology and Oncology IS is increased by a factor of 4.59 and approximate percentage change is 45.99% when compared to preceding year 2019, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Journal of Hematology and Oncology Impact Score 2021 Prediction


IS 2020 of Journal of Hematology and Oncology is 14.57. If the same upward trend persists, impact score of joule may rise in 2021 as well.


Impact Score Trend


Year wise Impact Score (IS) of Journal of Hematology and Oncology. Based on Scopus data.


Year Impact Score (IS)
2021/2022 Coming Soon
2020 14.57
2019 9.98
2018 8.36
2017 7.21
2016 6.30
2015 6.75
2014 5.68

Journal of Hematology and Oncology h-index


  Table Setting

Journal of Hematology and Oncology has an h-index of 84. It means 84 articles of this journal have more than 84 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Journal of Hematology and Oncology ISSN


The ISSN of Journal of Hematology and Oncology is 17568722. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Journal of Hematology and Oncology Rank and SCImago Journal Rank (SJR)


The overall rank of Journal of Hematology and Oncology is 354. According to SCImago Journal Rank (SJR), this journal is ranked 4.305. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Journal of Hematology and Oncology Publisher


Table Setting

Journal of Hematology and Oncology is published by BioMed Central Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2008-2020. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Journal of Hematology and Oncology is J. Hematol. Oncol.. This abbreviation ('J. Hematol. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Journal of Hematology and Oncology


If your research field is/are related to Cancer Research (Q1); Hematology (Q1); Molecular Biology (Q1); Oncology (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Factor, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Etudes Rurales journal 30599 Editions EHESS: Ecole des Hautes Etudes en Sciences Sociales 11 0.13
Zootaxa journal 8144 Magnolia Press 87 1.07
2017 9th International Scientific Conference on Communication and Information Technologies, KIT 2017 - Proceedings conference and proceedings 25842 4 0.00
Acta Medica Iranica journal 18244 Teheran University of Medical Sciences 27 0.26
Dongbei Daxue Xuebao/Journal of Northeastern University journal 21952 Northeastern University 20 0.29
Journal of Atherosclerosis and Thrombosis journal 2177 Japan Atherosclerosis Society 73 3.70
2017 Systems of Signal Synchronization, Generating and Processing in Telecommunications, SINKHROINFO 2017 conference and proceedings 26533 7 0.00
Hungarian Journal of Legal Studies journal 22409 Akademiai Kiado 3 0.12
International Journal of Industrial and Systems Engineering journal 15758 Inderscience Enterprises Ltd. 27 0.85
IEEE Transactions on Cognitive Communications and Networking journal 2482 Institute of Electrical and Electronics Engineers Inc. 25 6.85

Check complete list



Year wise Impact Factor (IF) of Journal of Hematology and Oncology

Impact Factor Table

Year Impact Factor (IF)
2020/2021Coming Soon
2019 11.059
2018 8.731
2017 7.333
2016 6.350
2015 6.263
2014 4.812
2013 4.933
2012 4.458
2011 3.990
2010 2.934



Year wise Impact Score (IF) of Journal of Hematology and Oncology

Impact Score Table

Year Impact Score (IS)
2021/2022 Coming Soon
2020 14.57
2019 9.98
2018 8.36
2017 7.21
2016 6.30
2015 6.75
2014 5.68



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

See All

Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Blood
American Society of Hematology | United States

Lancet Haematology,The
Lancet Publishing Group | United Kingdom

Leukemia
Nature Publishing Group | United Kingdom

Blood Cancer Journal
Nature Publishing Group | United States

Haematologica
Ferrata Storti Foundation | Italy

Blood advances
American Society of Hematology | United States

Blood Reviews
Churchill Livingstone | United States

American Journal of Hematology
Wiley-Liss Inc. | United States

See All

Top Journals/Conferences in Molecular Biology

Nature Reviews Molecular Cell Biology
Nature Publishing Group | United Kingdom

Cell
Cell Press | United States

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Physiological Reviews
American Physiological Society | United States

Molecular Cell
Cell Press | United States

Annual Review of Plant Biology
Annual Reviews Inc. | United States

Cell Metabolism
Cell Press | United States

Nature Structural and Molecular Biology
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Lancet Oncology, The
Lancet Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Cancer Discovery
American Association for Cancer Research Inc. | United States

See All